N. Ali

Activity of Cabazitaxel in Metastatic or Inoperable Locally Advanced Dedifferentiated Liposarcoma: A Phase 2 Study of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG).

J. Blay, S. Litière, R. L. Hayward, 2022, JAMA oncology.

Impact of centralization of services on outcomes in a rare tumour: Retroperitoneal sarcomas.

G. Poston, H. Malik, R. Kalaiselvan, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

D. Jamieson, B. Seddon, P. Woll, 2017 .

Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'.

J. Blay, E. Wardelmann, S. Litière, 2020, European journal of cancer.

Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern Ireland

Robin L. Jones, P. Dileo, S. Strauss, 2020, Clinical Sarcoma Research.

Salivary VEGF - A Potential Breast Cancer Marker

A. Adhikari, Sayantan Santra, A. Chatterjee, 2018, Cancer and Clinical Oncology.

Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights

D. Wright, G. Lip, A. Olsson-Brown, 2022, Case Reports in Oncology.

Reply to: Considerations on "impact of centralization of services on outcomes in a rare tumour: Retroperitoneal sarcomas".

G. Poston, H. Malik, R. Kalaiselvan, 2019, European Journal of Surgical Oncology.

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

T. Hickish, N. Heaton, O. Garden, 2020, The Lancet. Oncology.

Neoadjuvant chemotherapy for bladder transitional cell carcinoma: a new standard of care?

S. Ngan, D. Mazhar, N. Ali, 2007, Future oncology.

Updated results of European Organization for Research and Treatment of Cancer (EORTC) phase 2 trial 1202 cabazitaxel in patients with metastatic or inoperable locally advanced dedifferentiated liposarcoma.

J. Blay, S. Litière, R. L. Hayward, 2021 .

Surgical management of large abdominal wall fibromatosis during pregnancy

P. Sutton, P. Rooney, C. Chandrasekar, 2019, BMJ Case Reports.

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata

P. Woll, P. Gaunt, C. Gaskell, 2023, British Journal of Cancer.

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

D. Jamieson, B. Seddon, P. Woll, 2017, The Lancet. Oncology.